Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced a share buyback on November 24, 2025, repurchasing 100,000 ordinary shares at $1.865 per share, totaling $186,500. Following this transaction, the company's issued ordinary share capital stands at 345,967,440, with 19,143,791 shares held in treasury, resulting in 326,823,649 total voting rights. This buyback is authorized by shareholders and will not exceed a premium to net asset value, with repurchased shares intended to be held in treasury.

Disclaimer*

UK 100

Latest directors dealings